Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Infections with human papillomaviruses (HPVs) are common among women and men [2].
HPV infections are thought to be among the most common sexually transmitted infections …

Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They
have been highly effective in preventing infection and disease caused by the vaccine types …

Introduction The aim was to assess cost-effectiveness of expanding the Swedish HPV-
vaccination program to include preadolescent boys, by comparing health-effects and costs …

Abstract Purpose The EORTC QLU-C10D is a new multi-attribute utility instrument derived
from the EORTC QLQ-C30, a widely used cancer-specific quality of life questionnaire. It …

Background Vaccine price is one of the most influential parameters in economic evaluations
of HPV vaccination programmes. Vaccine tendering is a cost-containment method widely …

Die Ständige Impfkommission (STIKO) hat auf ihrer 90. Sitzung am 5. Juni 2018 die
Standardimpfung gegen Humane Papillomviren (HPV) für Jungen beschlossen. Hierzu …

Vaccination is effective in preventing human papillomavirus (HPV) infection. It still remains
debatable whether males should be included in a vaccination program and unclear how to …

Objective To assess the health economic impact of cervical screening with liquid based
cytology (LBC) compared with conventional cytology (CC) in Germany. Methods An …

Objectives Economic evaluations of vaccines should accurately represent all relevant
economic and health consequences of vaccination, including losses due to adverse events …